March 30, 2026
We’re proud to share that as of March 1st, dr. Ingrid de Visser-Kamerling has officially stepped into the role of Chief Operating Officer at…
An important step forward in the fight against antimicrobial resistance (AMR). As antibiotics are losing effectiveness worldwide, bacteriophages are increasingly seen as a promising…
December 2, 2025
November 26, 2025
Today our COO Ingrid de Visser-Kamerling was live on the BNR Nieuwsradio with Koenraad Wiedhaup to talk about the recent developments in infectious disease…
November 25, 2025
Leiden, 26 November 2025 – INFECTA, a Dutch clinical research organization specializing in infectious diseases, has signed a collaboration agreement with AHAM Vastgoed for…
November 4, 2025
Celebrating our 1 year anniversary at the first FAST – Centre for Future Affordable Sustainable Therapy Development event today with cake!
…October 21, 2025
Today, our CEO Meta Roestenberg was live on BNR Zakendoen! In the interview, she outlined INFECTA’s approach: to accelerate the development of vaccines and…
October 15, 2025
This afternoon, our COO Ingrid de Visser-Kamerling gave a presentation at The World Vaccine Congress about the advantages and impact of using Controlled Human…
July 14, 2025
On Thursday 10 July, our COO Ingrid de Visser-Kamerling took part in a panel discussion during the PLNT Leiden Festival titled “What will the…
July 4, 2025
Yes, we did it! Cheers to our partnership! 🥂 Last Friday, we signed the Master Service Agreement between Centre for Human Drug Research (CHDR)…
